Porphyromonas gingivalis Lipopolysaccharide Weakly Activates M1 and M2 Polarized Mouse Macrophages but Induces Inflammatory Cytokines

ABSTRACT Porphyromonas gingivalis is associated with chronic periodontitis, an inflammatory disease of the tooth's supporting tissues. Macrophages are important in chronic inflammatory conditions, infiltrating tissue and becoming polarized to an M1 or M2 phenotype. As responses to stimuli differ between these phenotypes, we investigated the effect of P. gingivalis lipopolysaccharide (LPS) on M1 and M2 macrophages. M1 and M2 polarized macrophages were produced from murine bone marrow macrophages (BMMϕ) primed with gamma interferon (IFN-γ) or interleukin-4 (IL-4), respectively, and incubated with a low or high dose of P. gingivalis LPS or control TLR2 and TLR4 ligands. In M1-Mϕ, the high dose of P. gingivalis LPS (10 μg/ml) significantly increased the expression of CD40, CD86, inducible nitric oxide synthase, and nitric oxide secretion. The low dose of P. gingivalis LPS (10 ng/ml) did not induce costimulatory or antibacterial molecules but did increase the secretion of IL-1α, IL-6, IL-12p40, IL-12p70, and tumor necrosis factor alpha (TNF-α). P. gingivalis LPS marginally increased the expression of CD206 and YM-1, but it did enhance arginase expression by M2-Mϕ. Furthermore, the secretion of the chemokines KC, RANTES, eotaxin, and MCP-1 from M1, M2, and nonpolarized Mϕ was enhanced by P. gingivalis LPS. TLR2/4 knockout macrophages combined with the TLR activation assays indicated that TLR2 is the main activating receptor for P. gingivalis LPS and whole cells. In conclusion, although P. gingivalis LPS weakly activated M1-Mϕ or M2-Mϕ compared to control TLR ligands, it induced the secretion of inflammatory cytokines, particularly TNF-α from M1-Mϕ and IL-10 from M2-Mϕ, as well as chemotactic chemokines from polarized macrophages.

[1]  E. Reynolds,et al.  Macrophage Depletion Abates Porphyromonas gingivalis–Induced Alveolar Bone Resorption in Mice , 2014, The Journal of Immunology.

[2]  S. Gharib,et al.  MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosis , 2014, Journal of leukocyte biology.

[3]  C. Zenobia,et al.  Porphyromonas gingivalis Lipid A Phosphatase Activity Is Critical for Colonization and Increasing the Commensal Load in the Rabbit Ligature Model , 2013, Infection and Immunity.

[4]  S. Crean,et al.  Macrophage Subset Sensitivity to Endotoxin Tolerisation by Porphyromonas gingivalis , 2013, PloS one.

[5]  Cun-Yu Wang,et al.  Tetra- and Penta-Acylated Lipid A Structures of Porphyromonas gingivalis LPS Differentially Activate TLR4-Mediated NF-κB Signal Transduction Cascade and Immuno-Inflammatory Response in Human Gingival Fibroblasts , 2013, PloS one.

[6]  Sumita A. Jain,et al.  A Novel Class of Lipoprotein Lipase-Sensitive Molecules Mediates Toll-Like Receptor 2 Activation by Porphyromonas gingivalis , 2013, Infection and Immunity.

[7]  F. C. Gibson,et al.  Macrophage-Specific TLR2 Signaling Mediates Pathogen-Induced TNF-Dependent Inflammatory Oral Bone Loss , 2013, The Journal of Immunology.

[8]  G. Hajishengallis,et al.  The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.

[9]  P. Veith,et al.  PG0026 Is the C-terminal Signal Peptidase of a Novel Secretion System of Porphyromonas gingivalis♦ , 2012, The Journal of Biological Chemistry.

[10]  J. Moreira,et al.  Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5′-Nucleotidase , 2012, PloS one.

[11]  S. Galli,et al.  Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils , 2011, Nature Immunology.

[12]  K. Goldie,et al.  The outer membrane protein LptO is essential for the O‐deacylation of LPS and the co‐ordinated secretion and attachment of A‐LPS and CTD proteins in Porphyromonas gingivalis , 2011, Molecular microbiology.

[13]  D. Devine,et al.  Temperature-Dependent Modulation of Porphyromonas gingivalis Lipid A Structure and Interaction with the Innate Host Defenses , 2011, Infection and Immunity.

[14]  T. Ogawa,et al.  Bioactive mechanism of Porphyromonas gingivalis lipid A. , 2010, Periodontology 2000.

[15]  A. Puig-Kröger,et al.  Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. , 2010, Immunobiology.

[16]  R. Darveau,et al.  Periodontitis: a polymicrobial disruption of host homeostasis , 2010, Nature Reviews Microbiology.

[17]  E. Reynolds,et al.  Host immune responses to Porphyromonas gingivalis antigens. , 2010, Periodontology 2000.

[18]  Jace W. Jones,et al.  Human Toll‐like receptor 4 responses to P. gingivalis are regulated by lipid A 1‐ and 4′‐phosphatase activities , 2009, Cellular microbiology.

[19]  F. Tacke,et al.  Monocytes and macrophages as cellular targets in liver fibrosis. , 2009, Inflammation & allergy drug targets.

[20]  L. Kocgozlu,et al.  Variable Cell Responses to P. gingivalis Lipopolysaccharide , 2009, Journal of dental research.

[21]  J. J. Taylor,et al.  Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide , 2009, Clinical and experimental immunology.

[22]  Yu-Yen Chen,et al.  The RgpA-Kgp Proteinase-Adhesin Complexes of Porphyromonas gingivalis Inactivate the Th2 Cytokines Interleukin-4 and Interleukin-5 , 2009, Infection and Immunity.

[23]  E. Reynolds,et al.  Porphyromonas gingivalis RgpA-Kgp Proteinase-Adhesin Complexes Penetrate Gingival Tissue and Induce Proinflammatory Cytokines or Apoptosis in a Concentration-Dependent Manner , 2008, Infection and Immunity.

[24]  J. Mege,et al.  Macrophage Polarization in Bacterial Infections , 2008, The Journal of Immunology.

[25]  Lili Chen,et al.  Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS: , 2008 .

[26]  Lili Chen,et al.  Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1β, TNF-α and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS , 2008, Innate immunity.

[27]  N. Bostanci,et al.  Identification of a Second Lipopolysaccharide in Porphyromonas gingivalis W50 , 2008, Journal of bacteriology.

[28]  K. Watanabe,et al.  Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide. , 2007, Oral microbiology and immunology.

[29]  T. Ogawa,et al.  Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. , 2007, Frontiers in bioscience : a journal and virtual library.

[30]  T. Lawrence,et al.  Granulocyte-Macrophage Colony-Stimulating Factor (CSF) and Macrophage CSF-Dependent Macrophage Phenotypes Display Differences in Cytokine Profiles and Transcription Factor Activities: Implications for CSF Blockade in Inflammation1 , 2007, The Journal of Immunology.

[31]  T. Ogawa,et al.  Toll‐like receptor 4‐dependent recognition of structurally different forms of chemically synthesized lipid As of Porphyromonas gingivalis , 2007, Clinical and experimental immunology.

[32]  Xia Zhang,et al.  Biochemical and functional characterization of three activated macrophage populations , 2006, Journal of leukocyte biology.

[33]  X. Liu,et al.  Hemin-Dependent Modulation of the Lipid A Structure of Porphyromonas gingivalis Lipopolysaccharide , 2006, Infection and Immunity.

[34]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[35]  P. De Baetselier,et al.  Arginase-1 and Ym1 Are Markers for Murine, but Not Human, Alternatively Activated Myeloid Cells , 2005, The Journal of Immunology.

[36]  S. Akira,et al.  Lipopolysaccharide Preparation Extracted from Porphyromonas gingivalis Lipoprotein-Deficient Mutant Shows a Marked Decrease in Toll-Like Receptor 2-Mediated Signaling , 2005, Infection and Immunity.

[37]  D. Graves,et al.  Cytokine Profiling of Macrophages Exposed to Porphyromonas gingivalis, Its Lipopolysaccharide, or Its FimA Protein , 2005, Infection and Immunity.

[38]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[39]  T. Ogawa,et al.  Separation and structural analysis of lipoprotein in a lipopolysaccharide preparation from Porphyromonas gingivalis. , 2004, International immunology.

[40]  S. Way,et al.  Porphyromonas gingivalis Lipopolysaccharide Contains Multiple Lipid A Species That Functionally Interact with Both Toll-Like Receptors 2 and 4 , 2004, Infection and Immunity.

[41]  T. Wynn.  Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[42]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[43]  F. Bäckhed,et al.  Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. , 2003, Microbes and infection.

[44]  G. Seymour,et al.  Antigen-presenting cells in human periodontal disease tissues. , 2002, Oral microbiology and immunology.

[45]  R. Darveau,et al.  Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system. , 2002, Annals of periodontology.

[46]  S. Akira,et al.  Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway. , 2002, International immunology.

[47]  P. De Baetselier,et al.  Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages , 2002, Journal of leukocyte biology.

[48]  W. Secor.  Faculty Opinions recommendation of Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. , 2002 .

[49]  M. J. Cody,et al.  Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine Macrophages , 2001, Infection and Immunity.

[50]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[51]  E. Hounsell,et al.  Variable Carbohydrate Modifications to the Catalytic Chains of the RgpA and RgpB Proteases of Porphyromonas gingivalis W50 , 1999, Infection and Immunity.

[52]  M. Srivastava,et al.  Failure of macrophage activation in destructive periodontal disease , 1998, The Journal of pathology.

[53]  S. Socransky,et al.  Microbial complexes in subgingival plaque. , 1998, Journal of clinical periodontology.

[54]  A. C. Johannessen,et al.  Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. , 1995, Journal of clinical periodontology.

[55]  S. Gordon,et al.  Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.

[56]  L. J. Brown,et al.  Periodontal diseases and tooth loss. , 1993, Periodontology 2000.

[57]  H. Flad,et al.  Agonists and antagonists for lipopolysaccharide-induced cytokines. , 1993, Immunobiology.

[58]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[59]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[60]  A. Polson,et al.  Histologic studies on the extension of the inflammatory infiltrate in human periodontitis. , 1991, Journal of clinical periodontology.

[61]  H. Larjava,et al.  Altered distribution of type I collagen mRNA in periodontal disease. , 1989, Journal of periodontal research.

[62]  L. Sly,et al.  Generation and characterization of murine alternatively activated macrophages. , 2013, Methods in molecular biology.

[63]  Victor W H Ho,et al.  Derivation and characterization of murine alternatively activated (M2) macrophages. , 2009, Methods in molecular biology.

[64]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[65]  F. Nishimura,et al.  Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. , 2003, Journal of periodontology.

[66]  D. Hartmann,et al.  Immunohistochemical study of types I, III and IV collagen in fibrosis of diseased gingiva during chronic periodontitis: a light and electron microscopic study. , 1987, Journal of periodontal research.

[67]  O. Westphal.  Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure , 1965 .